Prosolia Enters Into Collaborative Research Agreement With University of Florida

INDIANAPOLIS--(BUSINESS WIRE)--Prosolia, Inc., the developer and manufacturer of innovative sample introduction and ionization devices for mass spectrometry, announced today that it has entered into a collaborative research agreement with University of Florida Departments of Chemistry and Pathology to develop translational science applications for health and disease using the Company’s flowprobe™ technology.

“We are delighted to be working with the University of Florida, Professors Rick Yost and Tim Garrett on the development and application of our flowprobe technology for clinical research”

“Mass spectrometry has become an incredibly important tool for clinical analysis, as evidenced by the rapid growth of the MSACL conference, and that growth will only accelerate as mass spec delivers more sensitive and selective clinical assays, and solves new problems that can’t be addressed by other analytical techniques. One of the most exciting areas is direct analysis of tissues by mass spec, including imaging drugs and biomarkers directly in tissues. Although MALDI mass spectrometry has been the dominant player in this area, new sampling/ionization techniques such as DESI and surface microextraction (flowprobe™) are promising for clinical analysis, particularly for their ability to analyze tissue under ambient conditions,” said Dr. Rick Yost, Professor of Chemistry and Director of the Southeast Center for Integrated Metabolomics.

“We are delighted to be working with the University of Florida, Professors Rick Yost and Tim Garrett on the development and application of our flowprobe technology for clinical research,” said Justin Wiseman, President & CEO, Prosolia, Inc.

About Prosolia, Inc.

Prosolia is the leading developer and manufacturer of direct mass spectrometric solutions, delivering innovative technologies since 2005. Our portfolio of scientific tools includes innovative sample introduction, ionization and surface analysis systems, along with intuitive software, all of which are part of workflows that reduce analytical complexity and yield faster time to results. The unique capabilities of DESI, flowprobe and Velox 360 provide its customers the benefits of reduced time-to-results and streamlined analytical workflows resulting in increased cost efficiencies.

Flowprobe is a trademark of Prosolia, Inc.